Inhibrx Biosciences, Inc. (INBX)

NASDAQ: INBX · Real-Time Price · USD

89.47

+2.06 (2.36%)

At close: Dec 5, 2025, 4:00 PM EST

90.06

+0.59 (0.66%)

After-hours: Dec 5, 2025, 7:32 PM EST

Inhibrx Biosciences Stock Forecast

Stock Price Forecast

There is currently no analyst price target forecast available for Inhibrx Biosciences.

Analyst Consensus: Hold

Target	Low	Average	Median	High
Price	n/a	n/a	n/a	n/a
Change	n/a	n/a	n/a	n/a

Analyst Ratings

The average analyst rating for Inhibrx Biosciences stock from 2 stock analysts is "Hold". This means that analysts believe this stock is likely to perform similarly to the overall market.

Recommendation Trends

Rating	Jul '25	Aug '25	Sep '25	Oct '25	Nov '25	Dec '25
Strong Buy	0	0	0	0	0	0
Buy	0	0	0	0	0	0
Hold	1	2	2	2	2	2
Sell	0	0	0	0	0	0
Strong Sell	0	0	0	0	0	0
Total	1	2	2	2	2	2

Latest Forecasts

Analyst	Firm	Rating	Rating	Action	Price Target	Upside	Date
Reni J. Benjamin JMP Securities	JMP Securities	Hold Reiterates n/a	Hold	Reiterates	n/a	n/a	Aug 22, 2025
Reni Benjamin JMP Securities	JMP Securities	Hold Reiterates n/a	Hold	Reiterates	n/a	n/a	May 15, 2025
Reni Benjamin Citizens Capital Markets	Citizens Capital Markets	Hold Reiterates n/a	Hold	Reiterates	n/a	n/a	Mar 18, 2025
Reni Benjamin JMP Securities	JMP Securities	Hold Reiterates n/a	Hold	Reiterates	n/a	n/a	Jan 22, 2025
Reni Benjamin JMP Securities	JMP Securities	Hold Initiates n/a	Hold	Initiates	n/a	n/a	Jul 23, 2024

More Analyst Ratings

Financial Forecast

Revenue This Year

1.33M

from 200.00K

563.00%

from 200.00K

Revenue Next Year

4.39M

from 1.33M

230.77%

from 1.33M

EPS This Year

-9.19

from 112.62

EPS Next Year

-4.85

from -9.19

Fiscal Year	FY 2022	FY 2023	FY 2024	FY 2025	FY 2026	FY 2028	FY 2029
Period Ending	Dec 31, 2022	Dec 31, 2023	Dec 31, 2024	Dec 31, 2025	Dec 31, 2026	Dec 31, 2028	Dec 31, 2029
Revenue	1.32M	1.80M	200.00K	1.33M	4.39M	99.60M	131.83M
Revenue Growth	-	36.88%	-88.89%	563.00%	230.77%	2,170.77%	32.36%
EPS	-2.67	-20.48	112.62	-9.19	-4.85	-2.81	-1.16
EPS Growth	-	-	-	-	-	-	-
Forward PE	-	-	-	-	-	-	-
No. Analysts	-	-	-	3	3	3	3

Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.

Revenue Forecast

Revenue	2025	2026
High	1.4M	4.5M
Avg	1.3M	4.4M
Low	1.3M	4.2M

Revenue Growth

Revenue Growth	2025	2026
High	582.5%	240.5%
Avg	563.0%	230.8%
Low	537.0%	217.8%

EPS Forecast

EPS	2025	2026
High	-9.46	-5.00
Avg	-9.19	-4.85
Low	-8.83	-4.66

EPS Growth

EPS Growth	2025	2026
High	-	-
Avg	-	-
Low	-	-

Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.